No Data
No Data
Express News | Exagen Reaches 1M Patient Tested Vy AVISE CTD Milestone
Exagen Inc. Achieves Key Milestone With 1,000,000th Patient Tested by AVISE CTD
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Exagen Inc. (NASDAQ:XGN) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Express News | Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the Avise® Ctd Platform